原发性弥漫型2型优势型慢性鼻窦炎手术治疗的专家共识。

IF 7.2 2区 医学 Q1 OTORHINOLARYNGOLOGY
Manon Blauwblomme, Christos Georgalas, Shahzada Ahmed, Isam Alobid, Paolo Battaglia, Paolo Castelnuovo, Jannis Constantinidis, Iacopo Dallan, Anne-Sophie Eeckels, Marco Ferrari, Philippe Gevaert, Jessica Grayson, Richard Harvey, Philippe Herman, Iordanis Konstantinidis, Darlene Lubbe, Cem Meco, James Palmer, Zara M. Patel, Agnieszka Strzembosz, Benjamin Verillaud, Bradford A. Woodworth, Thibaut Van Zele
{"title":"原发性弥漫型2型优势型慢性鼻窦炎手术治疗的专家共识。","authors":"Manon Blauwblomme,&nbsp;Christos Georgalas,&nbsp;Shahzada Ahmed,&nbsp;Isam Alobid,&nbsp;Paolo Battaglia,&nbsp;Paolo Castelnuovo,&nbsp;Jannis Constantinidis,&nbsp;Iacopo Dallan,&nbsp;Anne-Sophie Eeckels,&nbsp;Marco Ferrari,&nbsp;Philippe Gevaert,&nbsp;Jessica Grayson,&nbsp;Richard Harvey,&nbsp;Philippe Herman,&nbsp;Iordanis Konstantinidis,&nbsp;Darlene Lubbe,&nbsp;Cem Meco,&nbsp;James Palmer,&nbsp;Zara M. Patel,&nbsp;Agnieszka Strzembosz,&nbsp;Benjamin Verillaud,&nbsp;Bradford A. Woodworth,&nbsp;Thibaut Van Zele","doi":"10.1002/alr.23538","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Chronic rhinosinusitis (CRS) poses significant challenges in surgical management due to the lack of clear guidelines, particularly in type 2 CRS. This review focuses on surgical approaches for primary diffuse type 2-dominant CRS, emphasizing preoperative and intraoperative strategies.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A consensus group, comprising experts from Europe, United Kingdom, Australia, South Africa, North and South America, was assembled. Using a modified Delphi method, 67 statements were formulated following a literature review, with an additional statement added in the second iteration. Final recommendations were discussed during a consensus meeting in Santorini, Greece, in October 2023.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Out of the 68 proposed statements, consensus was achieved on 45. Most (34) statements received a median score of 7 (strongly agree), and 11 had a median score of 6 (agree). The finalized recommendations cover the indications, timing, extent of surgery, and intraoperative management for both primary and revision surgery in primary diffuse type 2-dominant CRS. A key focus is on complete sinus surgery, which involves creating a neo-sinus cavity by removing bone partitions in the ethmoid and opening the frontal and sphenoidal sinuses as needed. Adequate primary and revision surgery includes clearing all nasal polyps and diseased mucosa while ensuring ideal conditions for topical therapy. Additionally, there was consensus on performing complete sinus surgery before considering monoclonal antibody therapies, unless contraindicated.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>These 45 consensus statements, derived from both current evidence and expert opinion, provide valuable guidance for clinicians in the surgical management of primary diffuse type 2-dominant CRS.</p>\n </section>\n </div>","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":"15 3","pages":"303-316"},"PeriodicalIF":7.2000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alr.23538","citationCount":"0","resultStr":"{\"title\":\"Expert Consensus on Surgical Management of Primary Diffuse Type 2-Dominant Chronic Rhinosinusitis\",\"authors\":\"Manon Blauwblomme,&nbsp;Christos Georgalas,&nbsp;Shahzada Ahmed,&nbsp;Isam Alobid,&nbsp;Paolo Battaglia,&nbsp;Paolo Castelnuovo,&nbsp;Jannis Constantinidis,&nbsp;Iacopo Dallan,&nbsp;Anne-Sophie Eeckels,&nbsp;Marco Ferrari,&nbsp;Philippe Gevaert,&nbsp;Jessica Grayson,&nbsp;Richard Harvey,&nbsp;Philippe Herman,&nbsp;Iordanis Konstantinidis,&nbsp;Darlene Lubbe,&nbsp;Cem Meco,&nbsp;James Palmer,&nbsp;Zara M. Patel,&nbsp;Agnieszka Strzembosz,&nbsp;Benjamin Verillaud,&nbsp;Bradford A. Woodworth,&nbsp;Thibaut Van Zele\",\"doi\":\"10.1002/alr.23538\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Chronic rhinosinusitis (CRS) poses significant challenges in surgical management due to the lack of clear guidelines, particularly in type 2 CRS. This review focuses on surgical approaches for primary diffuse type 2-dominant CRS, emphasizing preoperative and intraoperative strategies.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>A consensus group, comprising experts from Europe, United Kingdom, Australia, South Africa, North and South America, was assembled. Using a modified Delphi method, 67 statements were formulated following a literature review, with an additional statement added in the second iteration. Final recommendations were discussed during a consensus meeting in Santorini, Greece, in October 2023.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Out of the 68 proposed statements, consensus was achieved on 45. Most (34) statements received a median score of 7 (strongly agree), and 11 had a median score of 6 (agree). The finalized recommendations cover the indications, timing, extent of surgery, and intraoperative management for both primary and revision surgery in primary diffuse type 2-dominant CRS. A key focus is on complete sinus surgery, which involves creating a neo-sinus cavity by removing bone partitions in the ethmoid and opening the frontal and sphenoidal sinuses as needed. Adequate primary and revision surgery includes clearing all nasal polyps and diseased mucosa while ensuring ideal conditions for topical therapy. Additionally, there was consensus on performing complete sinus surgery before considering monoclonal antibody therapies, unless contraindicated.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>These 45 consensus statements, derived from both current evidence and expert opinion, provide valuable guidance for clinicians in the surgical management of primary diffuse type 2-dominant CRS.</p>\\n </section>\\n </div>\",\"PeriodicalId\":13716,\"journal\":{\"name\":\"International Forum of Allergy & Rhinology\",\"volume\":\"15 3\",\"pages\":\"303-316\"},\"PeriodicalIF\":7.2000,\"publicationDate\":\"2025-02-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alr.23538\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Forum of Allergy & Rhinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/alr.23538\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Forum of Allergy & Rhinology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/alr.23538","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:慢性鼻窦炎(CRS)由于缺乏明确的指南,特别是2型CRS,在外科治疗中面临着重大挑战。本文综述了原发性弥漫性2型CRS的手术入路,强调了术前和术中策略。方法:由来自欧洲、英国、澳大利亚、南非、北美和南美的专家组成的共识小组。采用改进的德尔菲法,在文献回顾后制定了67个语句,并在第二次迭代中增加了一个额外的语句。2023年10月在希腊圣托里尼举行的协商一致会议上讨论了最终建议。结果:在68项建议声明中,有45项达成共识。大多数(34个)陈述的中位数得分为7(非常同意),11个的中位数得分为6(同意)。最终的建议涵盖了原发性弥漫性2型CRS的原发性和翻修手术的适应症、时间、手术范围和术中管理。一个关键的焦点是完整的鼻窦手术,包括通过去除筛内的骨隔板并根据需要打开额窦和蝶窦来创建一个新鼻窦腔。适当的初级和翻修手术包括清除所有鼻息肉和病变粘膜,同时确保局部治疗的理想条件。此外,除非有禁忌症,否则在考虑单克隆抗体治疗之前进行完整的鼻窦手术是一致的。结论:基于现有证据和专家意见的45项共识声明,为临床医生对原发性弥漫性2型CRS的手术治疗提供了有价值的指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Expert Consensus on Surgical Management of Primary Diffuse Type 2-Dominant Chronic Rhinosinusitis

Expert Consensus on Surgical Management of Primary Diffuse Type 2-Dominant Chronic Rhinosinusitis

Background

Chronic rhinosinusitis (CRS) poses significant challenges in surgical management due to the lack of clear guidelines, particularly in type 2 CRS. This review focuses on surgical approaches for primary diffuse type 2-dominant CRS, emphasizing preoperative and intraoperative strategies.

Methods

A consensus group, comprising experts from Europe, United Kingdom, Australia, South Africa, North and South America, was assembled. Using a modified Delphi method, 67 statements were formulated following a literature review, with an additional statement added in the second iteration. Final recommendations were discussed during a consensus meeting in Santorini, Greece, in October 2023.

Results

Out of the 68 proposed statements, consensus was achieved on 45. Most (34) statements received a median score of 7 (strongly agree), and 11 had a median score of 6 (agree). The finalized recommendations cover the indications, timing, extent of surgery, and intraoperative management for both primary and revision surgery in primary diffuse type 2-dominant CRS. A key focus is on complete sinus surgery, which involves creating a neo-sinus cavity by removing bone partitions in the ethmoid and opening the frontal and sphenoidal sinuses as needed. Adequate primary and revision surgery includes clearing all nasal polyps and diseased mucosa while ensuring ideal conditions for topical therapy. Additionally, there was consensus on performing complete sinus surgery before considering monoclonal antibody therapies, unless contraindicated.

Conclusion

These 45 consensus statements, derived from both current evidence and expert opinion, provide valuable guidance for clinicians in the surgical management of primary diffuse type 2-dominant CRS.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.70
自引率
10.90%
发文量
185
审稿时长
6-12 weeks
期刊介绍: International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信